- Detailed analysis of the pipeline for RA by stage of development , molecule type , program type , mechanism of action , and molecular target , as well as analysis of recent clinical trials by enrollment , duration , failure rate , and promising late-stage pipeline molecules
- Forecasts for the RA market , including epidemiology , treatment usage pattern , pricing , and market size for the 2013 – 2020 period , for which data are presented at country level with further analysis of key market drivers and barriers
- Major deals that have taken place in the global RA market since 2006 , analyzing licensing and codevelopment agreements by stage of development , year , molecule type , mechanism of action and value ; network graphs of these deals are also included
Reasons to buy
Primarily , the report will allow clients to gain a strong understanding of RA , helping to identify and clarify market opportunities and the competitive environment . It will also allow you to -
- Understand the RA pipeline and the key trends in the current product development landscape
- Observe detailed profiles for the promising pipeline products , including revenue forecasts , and gain an insight into how they are likely to compete in the market , and what their main competitors will be
Download sample Copy of This Report at : http :// www . radiantinsights . com / research / rheumatoid-arthritis-market-to-2020-acrowded-market-characterized-by-modest-growth / request-sample
- Follow the trends in RA clinical trial size and duration in relation to industry averages and assess the potential risk of future developmental programs for RA therapeutics , depending on the mechanism of action , by considering the recorded clinical trial failure rates
- Observe the potential growth patterns expected for the RA market over the forecast period , and identify which countries are expected to make the biggest contribution to this growth
Table of Contents 1 Table of Contents 4 1.1 List of Tables 7 1.2 List of Figures 7
Follow Us :